Sen. Johnson 36th Oversight Letter to Federal Health Agencies Highlights Lack of Transparency and Agencies' Arrogance Towards the American People
On Wednesday,
There have been a growing number of adverse event reports in individuals who received the COVID-19 vaccine. These concerning reports have failed to result in health agencies taking action, seeking explanations or sharing that information with the American people. The response instead has been that of
In
The senator wrote, "The reported DMED data and the OneAmerica and BKK ProVita insurance data should heighten the concern over adverse events reports in VAERS that are currently being ignored. Even though reports of adverse events following vaccination continue to grow, federal health officials continue to ignore or downplay these alarming indicators."
Read more about the letter in The Federalist (https://thefederalist.com/2022/03/24/johnson-fda-cdc-refuse-to-comply-with-senate-oversight-on-covid-treatments/).
* * *
Dear Secretary Becerra,
To date, I have written 35 letters to the Executive Branch asking questions related to the COVID-19 pandemic and the federal government's response to it. The grossly inadequate response to my legitimate oversight demonstrates a level of arrogance toward the American public that is unacceptable. In particular, the lack of transparency from federal health agencies has eroded public confidence in the agencies you represent which will take years, and probably a complete restructuring of them, to repair. Nevertheless, I write again to request a response to developing events.
Data from a number of sources should be raising concerns regarding adverse events connected with the global mass COVID-19 vaccination campaign. The extent to which federal health agencies have ignored the vaccine safety signals coming from the Vaccine Adverse Event Reporting System (VAERS) is mind-boggling. As of
In
Mr. Schofbeck's experience is similar to what I have heard from many individuals, physicians and medical professionals across the
Similarly, disconcerting information was presented in
Additionally, in
The reported DMED data and the OneAmerica and BKK ProVita insurance data should heighten the concern over adverse events reports in VAERS that are currently being ignored. Even though reports of adverse events following vaccination continue to grow, federal health officials continue to ignore or downplay these alarming indicators.
The American people deserve complete transparency about the extent to which public health officials are aware of and responding to reports of adverse events following COVID-19 vaccination. Accordingly, please provide the following information:
1. Is your agency aware of Mr. Schofbeck's
2. Has your agency assessed whether the BKK ProVita data on potential significant underreporting of COVID-19 vaccine adverse reactions is accurate?
3. There are generally two shortfalls cited for VAERS: 1) VAERS does not prove causation; and 2) VAERS dramatically underreports the number of adverse events (a Harvard study estimated only 1% of adverse events get reported to VAERS)./15 The data out of
4. What has your agency undertaken to determine whether
5. What has your agency undertaken to determine whether
6. Are you concerned by the adverse events reported in VAERS associated with COVID-19 vaccination? If so, please explain what steps, if any, you taking to address those reports. If not, why are 1,183,495 reports of adverse events associated with vaccination not a concern to you?
7. Why is the
Please provide this information as soon as possible but no later than
Sincerely,
* * *
Footnotes:
1/ See VAERS Database query:
2/
3/ Letter from Andreas Schofbeck, Board Member, BKK ProVita, to Klaus Cichuetk, President,
4/ Id.
5/ Id.
6/ Id.
7/
8/ See COVID-19: A Second Opinion: Roundtable Before the
9/
10/ Id.
11/ Id.
12/
13/ Supra note 6.
14/
15/ See
16/ Supra note 13 Letter from Andreas Schofbeck.
17/



Maine Senate Democrats: Brenner Bill to Help Coastal Homeowners Afford Flood Insurance Signed Into Law
House Oversight Chair Maloney, Rep. Bush Announce Hearing on Pathways to Universal Health Coverage
Advisor News
- DOL proposes new independent contractor rule; industry is ‘encouraged’
- Trump proposes retirement savings plan for Americans without one
- Millennials seek trusted financial advice as they build and inherit wealth
- NAIFA: Financial professionals are essential to the success of Trump Accounts
- Changes, personalization impacting retirement plans for 2026
More Advisor NewsAnnuity News
- F&G joins Voya’s annuity platform
- Regulators ponder how to tamp down annuity illustrations as high as 27%
- Annual annuity reviews: leverage them to keep clients engaged
- Symetra Enhances Fixed Indexed Annuities, Introduces New Franklin Large Cap Value 15% ER Index
- Ancient Financial Launches as a Strategic Asset Management and Reinsurance Holding Company, Announces Agreement to Acquire F&G Life Re Ltd.
More Annuity NewsHealth/Employee Benefits News
- How might carriers respond to drop in ACA enrollment?
- CalOptima reports steep membership drop as providers brace for surge in uninsured patients
- Why Hospitality Owners in South Carolina Need Specialized Group Health Insurance Guidance
- 'Insurance is not cheap': School board debates absorbing $1.3M premium hike
- Pennie cancellations mount as swelling costs drive enrollees away from health insurance
More Health/Employee Benefits NewsLife Insurance News